We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Software Platform Identifies and Characterizes Proteins and Peptides

By HospiMedica staff writers
Posted on 21 May 2008
A software platform was developed for the identification and characterization of proteins and peptides from mass spectrometry (MS) data.

Called Phenyx, the software was specifically designed to meet the concurrent demands of high-throughput MS data analysis and dynamic result assessment, while offering a flexible user-experience and adaptable architecture. More...
It is available in multiple formats and installation configurations to insure its availability to the entire scientific community.

Phenyx was developed by Geneva Bioinformatics (GeneBio; Geneva, Switzerland) in collaboration with the Swiss Institute of Bioinformatics (SIB). GeneBio SA and GE Healthcare Life Sciences Latin America (GEHC-LS; São Paulo, Brazil) have announced a distribution agreement whereby GEHC-LS will distribute GeneBio's Phenyx MS identification platform throughout Latin America. This deal follows the long lasting relationship between GE Healthcare and GeneBio concerning the distribution of GeneBio's Melanie imaging platform.

Under the terms of the agreement, GEHC-LS will distribute Phenyx within the Latin American market as the exclusive MS software component of their product range. The deal encompasses GeneBio's Phenyx (for MS-MS identification), Aldente (for PMF analysis) as well as Phenyx's Daemon and other MS related software products that GeneBio will be marketing in the future.


Related Links:
Phenyx
Geneva Bioinformatics
GE Healthcare

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
MRI System
nanoScan MRI 3T/7T
Half Apron
Demi
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.